Cytokines, cytokine gene polymorphisms and Helicobacter pylori infection: Friend or foe?

World Journal of Gastroenterology

Volumn 20, Issue 18, 2014, Pages 5235-5243

  Figueiredo, Camila A ^a   Marques, Cintia Rodrigues ^a   Costa, Ryan dos Santos ^a   da Silva, Hugo Bernardino F ^a   Alcantara Neves, Neuza M ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Cytokines; Helicobacter pylori; Immunity; Polymorphisms; Stomach cancer

Indexed keywords

CD4 ANTIGEN; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G2; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 23; INTERLEUKIN 32; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; PATTERN RECOGNITION RECEPTOR; STAT4 PROTEIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; UREASE;

BACTERIAL COLONIZATION; BACTERIAL SURVIVAL; CELL ELONGATION; CELL MATURATION; CELL PROLIFERATION; DISEASE ASSOCIATION; DNA POLYMORPHISM; GASTRITIS; GASTROINTESTINAL DISEASE; HELICOBACTER INFECTION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION RISK; INFLAMMATION; INTESTINE METAPLASIA; MAJOR HISTOCOMPATIBILITY COMPLEX; REVIEW; RISK FACTOR; SEROPREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH ACID SECRETION; STOMACH ADENOCARCINOMA; ANIMAL; BLOOD; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; PHENOTYPE;

ANIMALS; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 84900460078     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i18.5235     Document Type: Review

References (80)

1. Ruggiero P. Helicobacter pylori and inflammation. Curr Pharm Des 2010; 16: 4225-4236 [PMID: 21184659 DOI: 10.217 4/138161210794519075]
2. Lamb A, Chen LF. Role of the Helicobacter pylori-induced inflammatory response in the development of gastric cancer. J Cell Biochem 2013; 114: 491-497 [PMID: 22961880 DOI: 10.1002/jcb.24389]
3. Wu MS, Chen CJ, Lin JT. Host-environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 1878-1882 [PMID: 16103430 DOI: 10.1158/1055-9965.EPI-04-0792]
4. Azevedo NF, Huntington J, Goodman KJ. The epidemiology of Helicobacter pylori and public health implications. Helicobacter 2009; 14 Suppl 1: 1-7 [PMID: 19712161 DOI: 10.1111/j.1523-5378.2009.00703.x]
5. Dattoli VC, Veiga RV, da Cunha SS, Pontes-de-Carvalho LC, Barreto ML, Alcântara-Neves NM. Seroprevalence and potential risk factors for Helicobacter pylori infection in Brazilian children. Helicobacter 2010; 15: 273-278 [PMID: 20633188 DOI: 10.1111/j.1523-5378.2010.00766.x]
6. Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 2011; 16 Suppl 1: 1-9 [PMID: 21896079 DOI: 10.1111/j.1523-5378.2011.00874.x]
7. Schoep TD, Fulurija A, Good F, Lu W, Himbeck RP, Schwan C, Choi SS, Berg DE, Mittl PR, Benghezal M, Marshall BJ. Surface properties of Helicobacter pylori urease complex are essential for persistence. PLoS One 2010; 5: e15042 [PMID: 21124783 DOI: 10.1371/journal.pone.0015042]
8. Voland P, Weeks DL, Marcus EA, Prinz C, Sachs G, Scott D. Interactions among the seven Helicobacter pylori proteins encoded by the urease gene cluster. Am J Physiol Gastrointest Liver Physiol 2003; 284: G96-G106 [PMID: 12388207 DOI: 10.1152/ajpgi.00160.2002]
9. McGee DJ, Mobley HL. Pathogenesis of Helicobacter pylori infection. Curr Opin Gastroenterol 2000; 16: 24-31 [PMID: 17024012]
10. Robinson K, Argent RH, Atherton JC. The inflammatory and immune response to Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 2007; 21: 237-259 [PMID: 17382275 DOI: 10.1016/j.bpg.2007.01.001]
11. Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol 2010; 7: 629-641 [PMID: 20938460 DOI: 10.1038/nrgastro.2010.154]
12. Backert S, Naumann M. What a disorder: proinflammatory signaling pathways induced by Helicobacter pylori. Trends Microbiol 2010; 18: 479-486 [PMID: 20863705 DOI: 10.1016/ j.tim.2010.08.003]
13. Caruso R, Pallone F, Monteleone G. Emerging role of IL-23/ IL-17 axis in H pylori-associated pathology. World J Gastroenterol 2007; 13: 5547-5551 [PMID: 17948927]
14. Watanabe T, Asano N, Fichtner-Feigl S, Gorelick PL, Tsuji Y, Matsumoto Y, Chiba T, Fuss IJ, Kitani A, Strober W. NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J Clin Invest 2010; 120: 1645-1662 [PMID: 20389019 DOI: 10.1172/JCI39481]
15. Suzuki T, Kato K, Ohara S, Noguchi K, Sekine H, Nagura H, Shimosegawa T. Localization of antigen-presenting cells in Helicobacter pylori-infected gastric mucosa. Pathol Int 2002; 52: 265-271 [PMID: 12031081]
16. Schmausser B, Andrulis M, Endrich S, Lee SK, Josenhans C, Müller-Hermelink HK, Eck M. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 2004; 136: 521-526 [PMID: 15147355 DOI: 10.1111/j.1365-2249.2004.02464.x]
17. Bimczok D, Clements RH, Waites KB, Novak L, Eckhoff DE, Mannon PJ, Smith PD, Smythies LE. Human primary gastric dendritic cells induce a Th1 response to H. pylori. Mucosal Immunol 2010; 3: 260-269 [PMID: 20237463 DOI: 10.1038/mi.2010.10]
18. Shimada M, Ando T, Peek RM, Watanabe O, Ishiguro K, Maeda O, Ishikawa D, Hasegawa M, Ina K, Ohmiya N, Niwa Y, Goto H. Helicobacter pylori infection upregulates interleukin-18 production from gastric epithelial cells. Eur J Gastroenterol Hepatol 2008; 20: 1144-1150 [PMID: 18946358 DOI: 10.1097/MEG.0b013e32830edb15]
19. Yamauchi K, Choi IJ, Lu H, Ogiwara H, Graham DY, Yamaoka Y. Regulation of IL-18 in Helicobacter pylori infection. J Immunol 2008; 180: 1207-1216 [PMID: 18178861]
20. Taylor JM, Ziman ME, Canfield DR, Vajdy M, Solnick JV. Effects of a Th1-versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice. Microb Pathog 2008; 44: 20-27 [PMID: 17683897 DOI: 10.1016/ j.micpath.2007.06.006]
21. Marotti B, Rocco A, De Colibus P, Compare D, de Nucci G, Staibano S, Tatangelo F, Romano M, Nardone G. Interleukin-13 mucosal production in Helicobacter pylori-related gastric diseases. Dig Liver Dis 2008; 40: 240-247 [PMID: 18243827 DOI: 10.1016/j.dld.2007.11.021]
22. Martínez-Becerra F, Castillo-Rojas G, Ponce de León S, López-Vidal Y. IgG subclasses against Helicobacter pylori isolates: an important tool for disease characterization. Scand J Immunol 2012; 76: 26-32 [PMID: 22686508 DOI: 10.1111/j.1365-3083.2012.02699.x]
23. Watanabe M, Kato J, Inoue I, Yoshimura N, Yoshida T, Mukoubayashi C, Deguchi H, Enomoto S, Ueda K, Maekita T, Iguchi M, Tamai H, Utsunomiya H, Yamamichi N, Fujishiro M, Iwane M, Tekeshita T, Mohara O, Ushijima T, Ichinose M. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis. Int J Cancer 2012; 131: 2632-2642 [PMID: 22383377 DOI: 10.1002/ ijc.27514]
24. Suzuki G, Cullings H, Fujiwara S, Hattori N, Matsuura S, Hakoda M, Akahoshi M, Kodama K, Tahara E. Low-positive antibody titer against Helicobacter pylori cytotoxinassociated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori. Cancer Epidemiol Biomarkers Prev 2007; 16: 1224-1228 [PMID: 17548689 DOI: 10.1158/1055-9965. EPI-06-1048]
25. Zhuang Y, Shi Y, Liu XF, Zhang JY, Liu T, Fan X, Luo J, Wu C, Yu S, Chen L, Luo P, Guo G, Liu Z, Tang B, Mao XH, Guo Y, Zou QM. Helicobacter pylori-infected macrophages induce Th17 cell differentiation. Immunobiology 2011; 216: 200-207 [PMID: 21112468 DOI: 10.1016/j.imbio.2010.05.005]
26. Khamri W, Walker MM, Clark P, Atherton JC, Thursz MR, Bamford KB, Lechler RI, Lombardi G. Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4+ T lymphocytes. Infect Immun 2010; 78: 845-853 [PMID: 19917709 DOI: 10.1128/IAI.00524-09]
27. Serelli-Lee V, Ling KL, Ho C, Yeong LH, Lim GK, Ho B, Wong SB. Persistent Helicobacter pylori specific Th17 responses in patients with past H. pylori infection are associated with elevated gastric mucosal IL-1β. PLoS One 2012; 7: e39199 [PMID: 22761739 DOI: 10.1371/journal. pone.0039199]
28. Ben-Sasson SZ, Hu-Li J, Quiel J, Cauchetaux S, Ratner M, Shapira I, Dinarello CA, Paul WE. IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc Natl Acad Sci USA 2009; 106: 7119-7124 [PMID: 19359475 DOI: 10.1073/pnas.0902745106]
29. Hitzler I, Kohler E, Engler DB, Yazgan AS, Müller A. The role of Th cell subsets in the control of Helicobacter infections and in T cell-driven gastric immunopathology. Front Immunol 2012; 3: 142 [PMID: 22675328 DOI: 10.3389/fimmu. 2012.00142]
30. Sakitani K, Hirata Y, Hayakawa Y, Serizawa T, Nakata W, Takahashi R, Kinoshita H, Sakamoto K, Nakagawa H, Akanuma M, Yoshida H, Maeda S, Koike K. Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation. Infect Immun 2012; 80: 3795-3803 [PMID: 22890997 DOI: 10.1128/IAI.00637-12]
31. Cheng HH, Tseng GY, Yang HB, Wang HJ, Lin HJ, Wang WC. Increased numbers of Foxp3-positive regulatory T cells in gastritis, peptic ulcer and gastric adenocarcinoma. World J Gastroenterol 2012; 18: 34-43 [PMID: 22228968 DOI: 10.3748/ wjg.v18.i1.34]
32. Chang LL, Wang SW, Wu IC, Yu FJ, Su YC, Chen YP, Wu DC, Kuo CH, Hung CH. Impaired dendritic cell maturation and IL-10 production following H. pylori stimulation in gastric cancer patients. Appl Microbiol Biotechnol 2012; 96: 211-220 [PMID: 22526791 DOI: 10.1007/s00253-012-4034-z]
33. Kandulski A, Wex T, Kuester D, Peitz U, Gebert I, Roessner A, Malfertheiner P. Naturally occurring regulatory T cells (CD4+, CD25high, FOXP3+) in the antrum and cardia are associated with higher H. pylori colonization and increased gene expression of TGF-beta1. Helicobacter 2008; 13: 295-303 [PMID: 18665940 DOI: 10.1111/j.1523-5378.2008.00612.x]
34. Mitchell PJ, Afzali B, Fazekasova H, Chen D, Ali N, Powell N, Lord GM, Lechler RI, Lombardi G. Helicobacter pylori induces in-vivo expansion of human regulatory T cells through stimulating interleukin-1β production by dendritic cells. Clin Exp Immunol 2012; 170: 300-309 [PMID: 23121671 DOI: 10.1111/j.1365-2249.2012.04659.x]
35. Oertli M, Sundquist M, Hitzler I, Engler DB, Arnold IC, Reuter S, Maxeiner J, Hansson M, Taube C, Quiding-Järbrink M, Müller A. DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. J Clin Invest 2012; 122: 1082-1096 [PMID: 22307326 DOI: 10.1172/JCI61029]
36. Tanaka H, Yoshida M, Nishiumi S, Ohnishi N, Kobayashi K, Yamamoto K, Fujita T, Hatakeyama M, Azuma T. The CagA protein of Helicobacter pylori suppresses the functions of dendritic cell in mice. Arch Biochem Biophys 2010; 498: 35-42 [PMID: 20363211 DOI: 10.1016/j.abb.2010.03.021]
37. Kao JY, Zhang M, Miller MJ, Mills JC, Wang B, Liu M, Eaton KA, Zou W, Berndt BE, Cole TS, Takeuchi T, Owyang SY, Luther J. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 2010; 138: 1046-1054 [PMID: 19931266 DOI: 10.1053/j.gastro.2009.11.043]
38. Freire de Melo F, Rocha AM, Rocha GA, Pedroso SH, de Assis Batista S, Fonseca de Castro LP, Carvalho SD, Bittencourt PF, de Oliveira CA, Corrêa-Oliveira R, Magalhães Queiroz DM. A regulatory instead of an IL-17 T response predominates in Helicobacter pylori-associated gastritis in children. Microbes Infect 2012; 14: 341-347 [PMID: 22155622 DOI: 10.1016/j.micinf.2011.11.008]
39. Serrano C, Wright SW, Bimczok D, Shaffer CL, Cover TL, Venegas A, Salazar MG, Smythies LE, Harris PR, Smith PD. Downregulated Th17 responses are associated with reduced gastritis in Helicobacter pylori-infected children. Mucosal Immunol 2013; 6: 950-959 [PMID: 23299619 DOI: 10.1038/ mi.2012.133]
40. Harris PR, Wright SW, Serrano C, Riera F, Duarte I, Torres J, Peña A, Rollán A, Viviani P, Guiraldes E, Schmitz JM, Lorenz RG, Novak L, Smythies LE, Smith PD. Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology 2008; 134: 491-499 [PMID: 18242215 DOI: 10.1053/j.gastro.2007.11.006]
41. Velin D, Favre L, Bernasconi E, Bachmann D, Pythoud C, Saiji E, Bouzourene H, Michetti P. Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model. Gastroenterology 2009; 136: 2237-2246. e1 [PMID: 19272385 DOI: 10.1053/ j.gastro.2009.02.077]
42. Arnold IC, Hitzler I, Müller A. The immunomodulatory properties of Helicobacter pylori confer protection against allergic and chronic inflammatory disorders. Front Cell Infect Microbiol 2012; 2: 10 [PMID: 22919602 DOI: 10.3389/ fcimb.2012.00010]
43. Reibman J, Marmor M, Filner J, Fernandez-Beros ME, Rogers L, Perez-Perez GI, Blaser MJ. Asthma is inversely associated with Helicobacter pylori status in an urban population. PLoS One 2008; 3: e4060 [PMID: 19112508 DOI: 10.1371/ journal.pone.0004060]
44. Bidwell JL, Wood NA, Morse HR, Olomolaiye OO, Laundy GJ. Human cytokine gene nucleotide sequence alignments, 1998. Eur J Immunogenet 1998; 25: 83-265 [PMID: 9615915]
45. Bidwell JL, Wood NA, Morse HR, Olomolaiye OO, Keen LJ, Laundy GJ. Human cytokine gene nucleotide sequence alignments: supplement 1. Eur J Immunogenet 1999; 26: 135-223 [PMID: 10331159]
46. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF, Rabkin CS. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402 [PMID: 10746728 DOI: 10.1038/35006081]
47. Ando T, El-Omar EM, Goto Y, Nobata K, Watanabe O, Maeda O, Ishiguro K, Minami M, Hamajima N, Goto H. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 2006; 55: 158-164 [PMID: 16120761]
48. Hartland S, Newton JL, Griffin SM, Donaldson PT. A functional polymorphism in the interleukin-1 receptor-1 gene is associated with increased risk of Helicobacter pylori infection but not with gastric cancer. Dig Dis Sci 2004; 49: 1545-1550 [PMID: 15481335]
49. Mayerle J, den Hoed CM, Schurmann C, Stolk L, Homuth G, Peters MJ, Capelle LG, Zimmermann K, Rivadeneira F, Gruska S, Völzke H, de Vries AC, Völker U, Teumer A, van Meurs JB, Steinmetz I, Nauck M, Ernst F, Weiss FU, Hofman A, Zenker M, Kroemer HK, Prokisch H, Uitterlinden AG, Lerch MM, Kuipers EJ. Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA 2013; 309: 1912-1920 [PMID: 23652523 DOI: 10.1001/ jama.2013.4350]
50. Queiroz DM, Rocha AM, Melo FF, Rocha GA, Teixeira KN, Carvalho SD, Bittencourt PF, Castro LP, Crabtree JE. Increased gastric IL-1β concentration and iron deficiency parameters in H. pylori infected children. PLoS One 2013; 8: e57420 [PMID: 23451225 DOI: 10.1371/journal. pone.0057420]
51. Queiroz DM, Saraiva IE, Rocha GA, Rocha AM, Gomes LI, Melo FF, Bittencourt PF. IL2-330G polymorphic allele is associated with decreased risk of Helicobacter pylori infection in adulthood. Microbes Infect 2009; 11: 980-987 [PMID: 19638314 DOI: 10.1016/j.micinf.2009.07.008]
52. Tseng FC, Brown EE, Maiese EM, Yeager M, Welch R, Gold BD, Owens M, Cranston B, Hanchard B, El-Omar E, Hisada M. Polymorphisms in cytokine genes and risk of Helicobacter pylori infection among Jamaican children. Helicobacter 2006; 11: 425-430 [PMID: 16961803 DOI: 10.1111/ j.1523-5378.2006.00433.x]
53. Achyut BR, Tripathi P, Ghoshal UC, Moorchung N, Mittal B. Interleukin-10 (-819 C/T) and tumor necrosis factor-alpha (-308 G/A) gene variants influence gastritis and lymphoid follicle development. Dig Dis Sci 2008; 53: 622-629 [PMID: 17717744 DOI: 10.1007/s10620-007-9925-y]
54. Chakravorty M, Datta De D, Choudhury A, Santra A, Roychoudhury S. Association of specific haplotype of TNFalpha with Helicobacter pylori-mediated duodenal ulcer in eastern Indian population. J Genet 2008; 87: 299-304 [PMID: 19147919 DOI: 10.1007/s12041-008-0048-9]
55. Chen CC, Yang SY, Liu CJ, Lin CL, Liaw YF, Lin SM, Lee SD, Chen PJ, Chen CJ, Yu MW. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int J Epidemiol 2005; 34: 1310-1318 [PMID: 16172101 DOI: 10.1093/ije/dyi191]
56. Gatti LL, Burbano RR, Zambaldi-Tunes M, de-Lábio RW, de Assumpção PP, de Arruda Cardoso-Smith M, Marques-Payão SL. Interleukin-6 polymorphisms, Helicobacter pylori infection in adult Brazilian patients with chronic gastritis and gastric adenocarcinoma. Arch Med Res 2007; 38: 551-555 [PMID: 17560462 DOI: 10.1016/j.arcmed.2006.12.011]
57. Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 2005; 26: 631-636 [PMID: 15579481]
58. Perri F, Piepoli A, Bonvicini C, Gentile A, Quitadamo M, Di Candia M, Cotugno R, Cattaneo F, Zagari MR, Ricciardiello L, Gennarelli M, Bazzoli F, Ranzani GN, Andriulli A. Cytokine gene polymorphisms in gastric cancer patients from two Italian areas at high and low cancer prevalence. Cytokine 2005; 30: 293-302 [PMID: 15927855 DOI: 10.1016/ j.cyto.2005.01.011]
59. Sugimoto M, Furuta T, Shirai N, Nakamura A, Kajimura M, Sugimura H, Hishida A. Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J Gastroenterol Hepatol 2007; 22: 1443-1449 [PMID: 17716348 DOI: 10.1111/ j.1440-1746.2006.04613.x]
60. Togawa S, Joh T, Itoh M, Katsuda N, Ito H, Matsuo K, Tajima K, Hamajima N. Interleukin-2 gene polymorphisms associated with increased risk of gastric atrophy from Helicobacter pylori infection. Helicobacter 2005; 10: 172-178 [PMID: 15904474 DOI: 10.1111/j.1523-5378.2005.00308.x]
61. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095-2147 [PMID: 8630372]
62. Rad R, Prinz C, Neu B, Neuhofer M, Zeitner M, Voland P, Becker I, Schepp W, Gerhard M. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 2003; 188: 272-281 [PMID: 12854083 DOI: 10.1086/376458]
63. Con SA, Takeuchi H, Con-Chin GR, Con-Chin VG, Yasuda N, Con-Wong R. Role of bacterial and genetic factors in gastric cancer in Costa Rica. World J Gastroenterol 2009; 15: 211-218 [PMID: 19132772 DOI: 10.3748/wjg.15.211]
64. Santos JC, Ladeira MS, Pedrazzoli J, Ribeiro ML. Relationship of IL-1 and TNF-α polymorphisms with Helicobacter pylori in gastric diseases in a Brazilian population. Braz J Med Biol Res 2012; 45: 811-817 [PMID: 22714811 DOI: 10.1590/S0100-879X2012007500099]
65. Shin WG, Jang JS, Kim HS, Kim SJ, Kim KH, Jang MK, Lee JH, Kim HJ, Kim HY. Polymorphisms of interleukin-1 and interleukin-2 genes in patients with gastric cancer in Korea. J Gastroenterol Hepatol 2008; 23: 1567-1573 [PMID: 18761558 DOI: 10.1111/j.1440-1746.2008.05479.x]
66. Xuan J, Deguchi R, Watanabe S, Ozawa H, Urano T, Ogawa Y, Fukuda R, Kijima H, Koga Y, Takagi A. Relationship between IL-1beta gene polymorphism and gastric mucosal IL-1beta levels in patients with Helicobacter pylori infection. J Gastroenterol 2005; 40: 796-801 [PMID: 16143884 DOI: 10.1007/s00535-005-1630-z]
67. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, Williams C, Ardill JE, McColl KE. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997; 113: 15-24 [PMID: 9207257]
68. Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 1997; 113: 1983-1991 [PMID: 9394739 DOI: 10.1016/ S0016-5085(97)70019-2]
69. Beales IL, Calam J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 1998; 42: 227-234 [PMID: 9536948 DOI: 10.1136/gut.42.2.227]
70. Wallace JL, Cucala M, Mugridge K, Parente L. Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol 1991; 261: G559-G564 [PMID: 1681735]
71. Basso D, Scrigner M, Toma A, Navaglia F, Di Mario F, Rugge M, Plebani M. Helicobacter pylori infection enhances mucosal interleukin-1 beta, interleukin-6, and the soluble receptor of interleukin-2. Int J Clin Lab Res 1996; 26: 207-210 [PMID: 8905454 DOI: 10.1007/BF02592984]
72. Jung HC, Kim JM, Song IS, Kim CY. Helicobacter pylori induces an array of pro-inflammatory cytokines in human gastric epithelial cells: quantification of mRNA for interleukin-8,-1 alpha/beta, granulocyte-macrophage colonystimulating factor, monocyte chemoattractant protein-1 and tumour necrosis factor-alpha. J Gastroenterol Hepatol 1997; 12: 473-480 [PMID: 9257236 DOI: 10.1111/j.1440-1746.1997. tb00469.x]
73. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994; 29: 425-429 [PMID: 8036458 DOI: 10.3109/00365529409096833]
74. Suárez A, Castro P, Alonso R, Mozo L, Gutiérrez C. Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation 2003; 75: 711-717 [PMID: 12640314 DOI: 10.1097/01.TP.0000055216.19866.9A]
75. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8 [PMID: 9043871 DOI: 10.1111/j.1365-2370.1997.tb00001.x]
76. Yea SS, Yang YI, Jang WH, Lee YJ, Bae HS, Paik KH. Association between TNF-alpha promoter polymorphism and Helicobacter pylori cagA subtype infection. J Clin Pathol 2001; 54: 703-706 [PMID: 11533078 DOI: 10.1136/jcp.54.9.703]
77. Seegers D, Zwiers A, Strober W, Peña AS, Bouma G. A TaqI polymorphism in the 3'UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 2002; 3: 419-423 [PMID: 12424624 DOI: 10.1038/sj.gene.6363919]
78. García-González MA, Lanas A, Wu J, Benito R, Santolaria S, Crusius B, Peña S. Lack of association of IL-12 p40 gene polymorphism with peptic ulcer disease. Hum Immunol 2005; 66: 72-76 [PMID: 15620465 DOI: 10.1016/j.humimm.2004.10.003]
79. Hou L, El-Omar EM, Chen J, Grillo P, Rabkin CS, Baccarelli A, Yeager M, Chanock SJ, Zatonski W, Sobin LH, Lissowska J, Fraumeni JF, Chow WH. Polymorphisms in Th1-type cellmediated response genes and risk of gastric cancer. Carcinogenesis 2007; 28: 118-123 [PMID: 16885196 DOI: 10.1093/carcin/ bgl130]
80. Navaglia F, Basso D, Zambon CF, Ponzano E, Caenazzo L, Gallo N, Falda A, Belluco C, Fogar P, Greco E, Di Mario F, Rugge M, Plebani M. Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals. J Med Genet 2005; 42: 503-510 [PMID: 15937086 DOI: 10.1136/jmg.2004.022723]